Prof Gray speaks at a SABCS 2017 press session about data from an EBCTCG meta-analysis study.
By increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs, reduced the risk of early-stage breast cancer recurrence and death compared with standard chemotherapy regimens.
Read the news story here.